9/20/2024 | IG | Market Commentary: Investment-grade primary action slows; Huntsman in Pipeline; high-grade fund inflows up
|
9/16/2024 | IG | New Issue: Novartis prices $3.7 billion of guaranteed notes in four tranches
|
9/16/2024 | IG | Novartis Capital aims to price fixed-rate notes in four parts
|
2/16/2024 | GNIG | Moody’s lifts Novartis
|
12/12/2023 | GNIG | DBRS assigns Novartis AA(low)
|
2/10/2023 | GNIG | Moody’s views Novartis positively
|
2/12/2020 | IG | New Issue: Novartis Capital details $5 billion of guaranteed notes in four parts
|
2/11/2020 | IG | New Issue: Novartis Capital prices $5 billion of guaranteed notes in four tranches
|
2/11/2020 | IG | Market Commentary: Morning Commentary: Novartis, Sysco, DTE, Oshkosh, Duke on tap; Carrier holds deal calls
|
2/11/2020 | IG | Novartis Capital aims to price fixed-rate notes in four parts
|
3/22/2019 | BKIG | Alcon lines up $4.2 billion bridge, term, revolving loans for spinoff
|
11/20/2018 | IG | Fitch downgrades Novartis
|
7/19/2018 | IG | Fitch: Novartis ratings unaffected
|
7/2/2018 | IG | Moody’s downgrades Novartis
|
9/18/2017 | IG | Fitch revises Novartis to negative
|
2/14/2017 | IG | New Issue: Novartis Capital prices $3 billion of guaranteed notes due 2020, 2022, 2027
|
2/14/2017 | IG | Novartis Capital plans sale of three-year, five-year, 10-year notes
|
1/26/2017 | IG | Moody’s: Novartis view to negative
|
11/17/2015 | IG | Market Commentary: High-grade primary sees $12 billion day; Time Warner prices; bonds mixed in secondary
|
11/17/2015 | IG | New Issue: Novartis Capital sells $3 billion of 10-, 30-year senior notes
|
11/17/2015 | IG | Novartis Capital intends to price offering of 10-, 30-year notes
|
2/18/2014 | IG | New Issue: Novartis Capital prices $4 billion notes in 10-, 30-year tranches
|
2/18/2014 | IG | Novartis Capital intends to price offering of 10-, 30-year notes
|
2/18/2014 | IG | Market Commentary: Novartis, Illinois Tool, PG&E lead $7.25 billion session; Ryder firms; Novartis eases
|
2/8/2013 | IG | Moody's downgrades Novartis
|
9/19/2012 | IG | New Issue: Novartis Capital gives terms of $2 billion sale of notes in 10-, 30-year tranches
|
9/19/2012 | IG | Market Commentary: JPMorgan, Vodafone, Franklin Resources keep deal flow alive; Church & Dwight, Novartis firm
|
9/19/2012 | IG | Market Commentary: Midday Commentary: 'Avalanche' of new issues continues; Novartis two-tranche deal tightens
|
9/18/2012 | IG | Novartis Capital prepares $2 billion offering of 10-, 30-year notes
|
9/18/2012 | IG | Novartis files automatic shelf registration to issue debt securities
|
9/18/2012 | IG | Market Commentary: Novartis, ING, Westpac, Total, NextEra among names in packed primary; banks, brokers mixed
|
11/9/2011 | IG | Fitch: Novartis view to stable
|
12/16/2010 | IG | Fitch: Novartis view to negative
|
12/16/2010 | IG | Moody's affirm Novartis
|
3/22/2010 | IG | Market Commentary: Duke Energy, Florida Power/Progress, Rabobank offer bonds; health names trade mixed post-bill
|
1/4/2010 | IG | Market Commentary: National Australia Bank sells two tranches, EIB, Dexia Credit plan bond sales; spreads firm
|
12/31/2009 | IG | Outlook 2010: Drug companies, money managers lead 2009's notable deals
|
6/25/2009 | IG | Market Commentary: Citigroup, Jefferies, Analog Devices, MassMutual, Torchmark sell notes; Merck busy, up again
|
2/6/2009 | IG | Market Commentary: Morgan Stanley, Citigroup tap primary; Caterpillar bonds falter; Altria gains; long bonds popular
|
2/5/2009 | IG | Market Commentary: Caterpillar Financial, Goldman Sachs sell bonds; new Altria, Novartis, CME gain; P&G notes flat
|
2/4/2009 | IG | New Issue: Novartis prices $5 billion of notes in five-, 10-year tranches
|
2/4/2009 | IG | Market Commentary: Novartis, Georgia Power, CME Group, Petrobras sell bonds, Novartis, Georgia Power trade up
|
2/3/2009 | IG | Market Commentary: Altria Group, P&G, Sunoco, Harley-Davidson, KfW sell bonds, Novartis plans issue
|
2/3/2009 | IG | Market Commentary: Altria Group, P&G, Sunoco, Harley-Davidson, KfW sell bonds, Novartis plans issue
|
2/3/2009 | IG | Novartis to price notes Wednesday in five-, 10-year tranches
|
9/26/2008 | CVIG | Novartis files automatic shelf registration
|